Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | XDH | P47989 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 2/20 | 0.48 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.48 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4368198 | 1.00 | SLC28A3 (0.54) | SLC28A3POLBXDHTDP1TYR | |
| SCHEMBL5193197 | 0.96 | TDP1 (0.55) | SLC28A3POLBXDHTDP1SLC5A1 | |
| SCHEMBL4371490 | 0.90 | SLC28A3 (0.55) | SLC28A3POLBXDHTDP1TYR | |
| SCHEMBL4366964 | 0.90 | SLC28A3 (0.55) | SLC28A3POLBXDHTDP1TYR | |
| SCHEMBL5180485 | 0.88 | ESR1 (0.50) | SLC28A3XDHTDP1TYR | |
| SCHEMBL1706259 | 0.88 | HSD17B2 (0.54) | SLC28A3XDH | |
| SCHEMBL5181210 | 0.87 | SLC28A3 (0.55) | SLC28A3POLBXDHTDP1 | |
| SCHEMBL5180718 | 0.87 | SLC28A3 (0.55) | SLC28A3POLBXDHTDP1 | |
| SCHEMBL4378546 | 0.87 | SLC28A3 (0.56) | SLC28A3POLBTYR | |
| SCHEMBL4375719 | 0.87 | SLC28A3 (0.56) | SLC28A3POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622563-B2 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20050272921-A1 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1544207-A1 | PROCESS FOR PRODUCING GLYCOSIDE | Mitsui Chemicals, Inc. (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272921-A1 | Process for producing glycoside | HAAO, OGA, MGAM | SLC28A3 3687/4885POLB 2382/4885XDH 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.